SOPHiA GENETICS S.A.

NASDAQ:SOPH

Medical - Healthcare Information Services

Healthcare
$7.47 +0.38%

+$0.02 today

Market cap
$635.90M
Beta
0.98
P/E (TTM)
-4.6
EPS (TTM)
-$1.14
52W Low $2.59High $5.70

Volume 0.61M

Average 0.10M

SOPH Other Non-current Assets

Long-term assets not reported separately.

SOPHiA GENETICS S.A.NASDAQ: SOPH

Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026

Other non-current assets rises 14.7% from a year ago

Other non-current assets stood at $6.75M at the end of Q1 FY2026, up 14.7% from a year earlier and up 8.8% from the prior quarter. Over 3 fiscal years it compounded at +13.2% a year.

Context

  • Other non-current assets amounted to 4.3% of total assets at the end of Q1 FY2026, up 0.3 pp from a year earlier.
  • Other non-current assets increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other non-current assets keeps rising in the next quarterly balance sheet after a +14.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.75M+8.8% QoQ
Last fiscal yearDec 2025
$6.21M+7.7% YoY
Year agoMar 2025
$5.88M+14.7% since
Other Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+14.7%——
1 year+7.7%——
3-year CAGR+13.2%——
5-year CAGR——
10-year CAGR——

Other Non-current Assets history

USD · from the balance sheet

Latest · FY2025
6.21M USD
Year-over-year change
+7.7%
4-year CAGR
+13.8%

Other Non-current Assets vs competitors

How SOPH compares with its peers on the latest reported figures

  • SOPH's Mar 2026 other non-current assets of $6.75M is the 4th highest of the 10 companies compared; the peer median is $5.95M.
  • Its year-over-year change of +14.7% is the 6th highest of 10, against a peer median of +33.6%.
  • Other non-current assets amounts to 4.3% of total assets for SOPH, versus a peer median of 1.5%.
SOPH Competitors Peer median
Other Non-current Assets for SOPH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TEMTempus AI, Inc.Sep 2026$166.9M +271.6%+6.7%6.8%
HSTMHealthStream, Inc.Mar 2026$93.41M +137.2%+46.9%17.7%
DHDefinitive Healthcare Corp.Mar 2026$26.76M +54.8%-7.8%5.2%
SOPHSOPHiA GENETICS S.A.Mar 2026$6.75M +14.7%+13.2%4.3%
HCATHealth Catalyst, Inc.Mar 2026$6.12M +10.8%+17.8%1.5%
NRCNational Research CorporationMar 2026$5.95M +41.2%+0.7%4.4%
BLLNBillionToOne, Inc.Jun 2026$5.56M -31.3%—0.8%
PSNLPersonalis, Inc.Mar 2026$3.8M +33.6%+11.0%1.2%
CERTCertara, Inc.Mar 2026$1.6M -20.3%-33.6%0.1%
OPRXOptimizeRx CorporationMar 2026$18K -92.1%+77.0%0.0%
Peer median (excluding SOPH) $5.95M+33.6%+8.9%1.5%

Competitors are the stored peer set for SOPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents192.96M161.31M123.25M80.23M70.29M
Short-term Investments72.36M17.31M000
Net Receivables7.09M8.05M15.21M8.69M18.53M
Inventory5.73M5.16M6.48M5.87M6.35M
Other Current Assets775K731K345K835K758K
Total Current Assets282.86M196.26M148.05M99.41M99.08M
Property, Plant & Equipment (Net)15.96M21.4M23.1M19.38M18.05M
Goodwill8.3M8.19M9M8.34M9.56M
Intangible Assets7.38M11.78M18.19M20.66M26.34M
Long-term Investments00001.98M
Tax Assets1.99M1.94M1.72M1.77M2.26M
Other Non-current Assets3.7M4.28M6.1M5.76M6.21M
Total Non-current Assets37.32M47.58M58.11M55.9M64.38M
Total Assets320.17M243.84M206.16M155.31M163.46M
Account Payables2.34M2.17M2.26M1.93M5.32M
Short-term Debt00000
Tax Payables891K356K769K658K0
Deferred Revenue4.07M3.43M9.49M5.73M16.72M
Other Current Liabilities9.16M10.27M13.58M11.23M1.68M
Total Current Liabilities28.6M26.81M35.62M26.8M50.53M
Long-term Debt00013.24M47.73M
Deferred Tax Liabilities0000424K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities4.92M2.85M3.42M4.18M5.04M
Total Non-current Liabilities16.17M16.9M19.09M32.02M65.78M
Total Liabilities44.77M43.71M54.71M58.82M116.31M
Common Stock3.33M3.46M4.05M4.19M4.81M
Retained Earnings(211.35M)(298.8M)(377.78M)(440.28M)(519.28M)
Accumulated OCI12.54M23.96M53.98M61.04M89.15M
Other Stockholders Equity00000
Minority Interest00000
Total Equity275.4M200.13M151.44M96.49M47.15M
Total Debt13.06M16.74M18.6M30.03M63.02M
Net Debt(179.9M)(144.56M)(104.65M)(50.2M)(7.27M)

SOPHiA GENETICS S.A.

NASDAQ:SOPH

Intrinsic Alpha fair value

Locked

Current Price

$7.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.